56 results
DRS
EX-10.2
STOK
Stoke Therapeutics Inc
26 Mar 19
Draft registration statement
12:00am
of an Option will always be subject to the following terms and conditions.
4.6.1 Other than Death or Disability or for Cause. If the Participant … is Terminated for any reason other than death, Disability or for Cause, then the Participant may exercise such Participant’s Options only to the extent
8-K
EX-99.2
STOK
Stoke Therapeutics Inc
10 Jan 22
Entry into a Material Definitive Agreement
7:01am
characterized by moderate to severe intellectual disability that is evident in early childhood. Mutations in the SYNGAP1 gene (which produces … by developmental delay or intellectual disability, generalized epilepsy, and autism spectrum disorder (ASD) and other behavioral abnormalities. More than 80
S-1
EX-10.2
STOK
Stoke Therapeutics Inc
23 May 19
IPO registration
4:02pm
be subject to the following terms and conditions.
4.6.1Other than Death or Disability or for Cause. If the Participant is Terminated for any reason other … than death, Disability or for Cause, then the Participant may exercise such Participant’s Options only to the extent that such Options
8-K
EX-99.1
STOK
Stoke Therapeutics Inc
10 Jan 22
Entry into a Material Definitive Agreement
7:01am
for Dravet Syndrome Non-Seizure Comorbidities of Dravet Syndrome Are Not Addressed by Current Therapies Intellectual disability Developmental delays … Syndrome Foundation; Operta et al., © Copyright 2022 Stoke Therapeutics 24 Brain Behav 2019
SYNGAP1 Syndrome: A Severe Intellectual Disability
S-1
EX-10.13
STOK
Stoke Therapeutics Inc
23 May 19
IPO registration
4:02pm
at any time without Cause for such termination (“Termination without Cause”); and
(e) your employment may terminate due to death or Disability … Reconciliation Act of 1985, as amended.
(d)Disability. For purposes of this Agreement, “Disability” shall have that meaning set forth in Section 22(e)(3
S-1
EX-10.10
k92666
23 May 19
IPO registration
4:02pm
S-1
EX-10.12
bkr6ypp5
23 May 19
IPO registration
4:02pm
S-1/A
EX-10.4
r1ob2h90igumbbco
7 Jun 19
IPO registration (amended)
6:08am
S-1
EX-10.11
w0zblw1l4e23n
23 May 19
IPO registration
4:02pm
S-1
EX-10.9
cmjyck bx
23 May 19
IPO registration
4:02pm
S-8
EX-99.1
ywvi7f9
13 Apr 23
Registration of securities for employees
4:02pm
8-K
EX-99.2
1slm8l
14 Nov 22
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
zu105cpp6 ng4u8
6 May 24
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
36zmv0c 8x9fxp8r2t
21 Sep 21
Other Events
7:06am
8-K
EX-99.1
2txrlgzp77ybsr
1 Dec 23
Regulation FD Disclosure
9:04am
8-K
EX-99.1
3ghzgu
2 Dec 22
Stoke Therapeutics Presents Data from a Combined Interim Analysis of the Phase 1/2a
9:05am